Board Meeting21 May 2026, 12:41 pm
Sudarshan Pharma to Migrate to Main Board of BSE and NSE
AI Summary
Sudarshan Pharma Industries Ltd's board approved the migration of its equity shares from the SME platform of BSE to the Main Board of BSE and NSE, subject to shareholder approval. They also approved the application for listing/trading on the Main Board of NSE. A postal ballot notice was approved to seek member approval for the migration. NSDL was appointed for remote e-voting, and Mr. Vishal Manseta was appointed as the scrutinizer for the postal ballot process.
Key Highlights
- Board approved migration of equity shares to the main board of BSE and NSE.
- Shareholder approval is required for the migration.
- NSDL appointed for remote e-voting for the postal ballot process.
- Vishal Manseta appointed as scrutinizer for e-voting process.
Price Impact
More from SUDARSHAN